Riverview Capital Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$721K Sell
2,950
-4,221
-59% -$983K 0.24% 50
2025
Q4
$1.48M Buy
7,171
+12
+0.2% +$2.37K 0.45% 46
2025
Q3
$1.33M Buy
7,159
+9
+0.1% +$1.54K 0.38% 48
2025
Q2
$1.09M Sell
7,150
-88
-1% -$13.5K 0.31% 59
2025
Q1
$1.2M Buy
7,238
+210
+3% +$32.9K 0.38% 55
2024
Q4
$1.02M Buy
7,028
+10
+0.1% +$1.55K 0.31% 56
2024
Q3
$1.14M Buy
7,018
+10
+0.1% +$1.59K 0.35% 49
2024
Q2
$1.02M Buy
7,008
+11
+0.2% +$1.64K 0.35% 52
2024
Q1
$1.11M Buy
6,997
+9
+0.1% +$1.43K 0.38% 47
2023
Q4
$1.1M Buy
6,988
+44
+0.6% +$6.75K 0.42% 45
2023
Q3
$1.08M Buy
6,944
+10
+0.1% +$1.65K 0.48% 49
2023
Q2
$1.15M Buy
6,934
+9
+0.1% +$1.45K 0.5% 46
2023
Q1
$1.07M Buy
6,925
+9
+0.1% +$1.45K 0.46% 49
2022
Q4
$1.22M Buy
6,916
+8
+0.1% +$1.38K 0.66% 38
2022
Q3
$1.13M Buy
6,908
+8
+0.1% +$1.35K 0.71% 41
2022
Q2
$1.22M Buy
6,900
+42
+0.6% +$7.48K 0.68% 42
2022
Q1
$1.22M Sell
6,858
-169
-2% -$28.8K 0.56% 43
2021
Q4
$1.2M Buy
+7,027
New +$1.15M 0.54% 43

Other funds holding JNJ

Riverview Capital Advisers's JNJ Position: Q1 2026 in Review

Riverview Capital Advisers reduced its Johnson & Johnson (JNJ) stake by 59% in Q1 2026, selling an estimated $983K and leaving 2,950 shares worth $721K. The position accounts for 0.24% of the portfolio, ranked #50.

Riverview Capital Advisers first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.48M in Q4 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Riverview Capital Advisers held 2,950 shares of Johnson & Johnson worth $721K as of Q1 2026.
  • Riverview Capital Advisers sold 4,221 Johnson & Johnson shares in Q1 2026, an estimated $983K.
  • Johnson & Johnson made up 0.24% of Riverview Capital Advisers's portfolio in Q1 2026, its #50 holding.
  • Riverview Capital Advisers first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • Riverview Capital Advisers's Johnson & Johnson position peaked at $1.48M in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Riverview Capital Advisers's 13F filing for Q1 2026, filed 14 May 2026.